TRADING MNKD , ETC

[TREND1]

Equity Coverage placed under Extended Review
We are placing the following equity securities under extended review due to
reallocation of resources. Investors should no longer rely upon our previously
published reports, recommendations, price objectives or estimates.
Table 1: Equity Coverage placed under Extended Review
Company name BofAML Ticker
ALKS Alkermes plc
ARNA Arena Pharma
ESPR Esperion
KPTI Karyopharm
MGNX MacroGenics
MNKD MannKind Corporation
MEIP MEI Pharma
NKTR Nektar
OREX Orexigen
PRTA Prothena
SRPT Sarepta
SGEN Seattle Genetics
MDCO The Medicines Co.
VVUS Vivus, Inc.
Source: BofA Merrill Lynch Global Research